MRK vs CVS
By Alex · Tickerpine
Merck & Co., Inc. vs CVS Health Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | CVS |
|---|---|---|
| Price | $128.66 | $104.34 |
| Market cap | $317.77B | $133.13B |
| P/E ratio | 36.2 | 45.6 |
| ROE | 18.94% | 3.75% |
| Profit margin | 13.59% | 0.72% |
| Revenue growth | 4.90% | 6.10% |
| Dividend yield | 2.64% | 2.55% |
| Beta | 0.22 | 0.62 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs CVS in plain English
- MRK is the bigger company — about 2.4× the market cap of CVS.
- MRK is cheaper on earnings (P/E 36.2 vs 45.6).
- MRK earns a higher return on equity (19% vs 4%).
- CVS is growing revenue faster (6% vs 5%).
- MRK has the higher dividend yield (2.64% vs 2.55%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
CVS return calculator
See what $1,000 in CVS Health Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.